![Sanjay Chanda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sanjay Chanda
Corporate Officer/Principal bij
AN2 THERAPEUTICS, INC.
Vermogen: 166 428 $ op 30-06-2026
Profiel
Dr. Sanjay Chanda is a Chief Development Officer at AN2 Therapeutics, Inc. and a Chief Development Officer at Cortene, Inc. Dr. Chanda was previously employed as a Co-Founder by Auration Biotech, Inc., a Senior Vice President-Drug Development by Anacor Pharmaceuticals LLC, and a Chief Development Officer by Tioma Therapeutics, Inc. He received his undergraduate degree from Birla Institute of Technology & Science, a graduate degree from Birla Institute of Technology & Science and a doctorate degree from Northeast Louisiana University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 34.386 ( 0,1% ) | 166 428 $ | 30-06-2026 |
Actieve functies van Sanjay Chanda
| Bedrijven | Functie | Begin |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2019 |
Cortene, Inc.
 Cortene, Inc. BiotechnologyHealth Technology Develops therapeutics for treating a broad range of disorders related to the stress response | Corporate Officer/Principal | 01-02-2017 |
Eerdere bekende functies van Sanjay Chanda
| Bedrijven | Functie | Einde |
|---|---|---|
Arch Oncology, Inc.
 Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Corporate Officer/Principal | 01-08-2017 |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01-10-2016 |
Auration Biotech, Inc.
 Auration Biotech, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of diseases of ear, nose and throat | Oprichter | - |
Opleiding van Sanjay Chanda
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
26
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Birla Institute of Technology & Science
 Birla Institute of Technology & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Northeast Louisiana University
 Northeast Louisiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arch Oncology, Inc.
Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Health Technology |
Auration Biotech, Inc.
Auration Biotech, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of diseases of ear, nose and throat | Health Technology |
AN2 Therapeutics, Inc.
 AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Cortene, Inc.
Cortene, Inc. BiotechnologyHealth Technology Develops therapeutics for treating a broad range of disorders related to the stress response | Health Technology |
Kies MarketScreener 
